Published in Mol Pharmacol on April 01, 2000
Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol (2002) 2.40
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev (2010) 2.10
Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol (2002) 2.06
Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med (2005) 1.79
Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol (2010) 1.73
Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J Biol Chem (2009) 1.53
Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochim Biophys Acta (2008) 1.43
A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells. J Cell Biol (2005) 1.40
NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation. Mol Cell Biol (2004) 1.37
Identification of a molecular target of psychosine and its role in globoid cell formation. J Cell Biol (2001) 1.32
Insights into the pharmacological relevance of lysophospholipid receptors. Br J Pharmacol (2012) 1.31
Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling. Cell Signal (2008) 1.28
Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol (2014) 1.21
Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol Biol Cell (2008) 1.20
The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells. Cell Commun Signal (2013) 1.20
Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. Biochim Biophys Acta (2007) 1.18
Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma. Respir Res (2009) 1.04
Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury. J Biol Chem (2009) 1.02
Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid. Endocrinology (2004) 1.00
Lipid phosphate phosphatase (LPP3) and vascular development. Biochim Biophys Acta (2012) 0.99
Lysophosphatidic acid (LPA) signaling in vertebrate reproduction. Trends Endocrinol Metab (2010) 0.94
Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptors. J Biol Chem (2008) 0.91
Lysophosphatidic acid effects on atherosclerosis and thrombosis. Clin Lipidol (2011) 0.91
Serotonergic neuron regulation informed by in vivo single-cell transcriptomics. FASEB J (2013) 0.89
LPA induces IL-6 secretion from aortic smooth muscle cells via an LPA1-regulated, PKC-dependent, and p38alpha-mediated pathway. Am J Physiol Heart Circ Physiol (2009) 0.88
LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cells. J Cell Physiol (2011) 0.88
A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor. BMC Biochem (2004) 0.87
Lysophospholipid signaling: beyond the EDGs. Biochim Biophys Acta (2007) 0.86
Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors. Acta Pharmacol Sin (2010) 0.86
Distribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain. Int J Mol Sci (2010) 0.83
Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2. Oncol Lett (2013) 0.77
The effect of lysophosphatidic acid during in vitro maturation of bovine oocytes: embryonic development and mRNA abundances of genes involved in apoptosis and oocyte competence. Mediators Inflamm (2014) 0.76
LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study. BMC Cancer (2016) 0.75
Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract. Mediators Inflamm (2014) 0.75
Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter. Exp Ther Med (2013) 0.75
Isolation of cDNA clones coding for the beta subunit of human beta-hexosaminidase. Proc Natl Acad Sci U S A (1985) 3.50
Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem (2000) 3.22
Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem (2000) 2.89
A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene (1993) 2.59
Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease. J Biol Chem (1986) 2.54
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature (1991) 2.41
Molecular cloning of rat renin cDNA and its gene. Proc Natl Acad Sci U S A (1987) 2.17
Characterization of apelin, the ligand for the APJ receptor. J Neurochem (2000) 2.11
Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem (1989) 2.10
Discovery of a receptor related to the galanin receptors. FEBS Lett (1999) 2.01
Molecular structure of a protein-tyrosine/threonine kinase activating p42 mitogen-activated protein (MAP) kinase: MAP kinase kinase. Proc Natl Acad Sci U S A (1993) 1.92
Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature (1988) 1.88
The structure and expression of very closely related members of the alpha 2u globulin gene family. J Biol Chem (1982) 1.85
Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem (1992) 1.76
Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist. Mol Pharmacol (2001) 1.74
Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res (1999) 1.68
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol (1992) 1.66
Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem (2000) 1.63
Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor. J Natl Cancer Inst (2000) 1.62
Discovery and mapping of ten novel G protein-coupled receptor genes. Gene (2001) 1.60
Identification of receptors for neuromedin U and its role in feeding. Nature (2000) 1.60
D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1991) 1.55
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci U S A (1991) 1.54
Recruitment of renin gene-expressing cells in adult rat kidneys. Am J Physiol (1990) 1.50
Discovery of three novel G-protein-coupled receptor genes. Genomics (1998) 1.50
A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem Biophys Res Commun (1997) 1.50
Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2. Mol Cell Biol (1993) 1.48
Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis. Cancer Metastasis Rev (1991) 1.46
Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem (1989) 1.45
Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol (1989) 1.45
Autosomal-dominant polycystic kidney disease in the rat. Kidney Int (1993) 1.44
Discovery of a novel member of the histamine receptor family. Mol Pharmacol (2001) 1.41
Evaluation of urinary continence and voiding function: early results in men with neo-urethral modification of the Hautmann orthotopic neobladder. J Urol (2001) 1.39
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metastasis (2000) 1.39
Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene. J Biol Chem (1995) 1.39
Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circ Res (1993) 1.38
Cloning and sequence of several alpha 2u-globulin cDNAs. Proc Natl Acad Sci U S A (1981) 1.37
Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med (2001) 1.37
Tissue-specific control of alpha 2u globulin gene expression: constitutive synthesis in the submaxillary gland. Cell (1983) 1.37
Molecular cloning of rat type 2C (IA) protein phosphatase mRNA. Proc Natl Acad Sci U S A (1989) 1.36
Localization of angiotensinogen messenger RNA in rat aorta. Circ Res (1988) 1.35
Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene (2001) 1.34
Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol (1988) 1.33
Identification of a molecular target of psychosine and its role in globoid cell formation. J Cell Biol (2001) 1.32
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun (1999) 1.32
Signalling properties of lysophosphatidic acid. Trends Pharmacol Sci (1993) 1.30
Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension (1986) 1.30
The heat shock response in HeLa cells is accompanied by elevated expression of the c-fos proto-oncogene. Mol Cell Biol (1987) 1.28
Spatial learning deficit in dopamine D(1) receptor knockout mice. Eur J Pharmacol (1999) 1.27
Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol (1993) 1.27
Cloning of human genes encoding novel G protein-coupled receptors. Genomics (1994) 1.26
A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature (1992) 1.26
Renin and angiotensinogen gene expression in maturing rat kidney. Am J Physiol (1988) 1.26
Astrocytes synthesize angiotensinogen in brain. Science (1988) 1.25
Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer. Genes Chromosomes Cancer (2000) 1.24
FMRFamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54. Biochem Biophys Res Commun (2001) 1.20
Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol (1994) 1.20
Neuropathologic features in adults with 22q11.2 deletion syndrome. Cereb Cortex (2008) 1.19
Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun (1996) 1.18
Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis). J Biol Chem (1986) 1.18
Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene (2006) 1.17
Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Commun (1993) 1.17
A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. J Biol Chem (1994) 1.14
Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int (2008) 1.14
Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior. Eur J Pharmacol (1998) 1.14
Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol (1996) 1.14
Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol (1996) 1.12
Prolonged fear responses in mice lacking dopamine D1 receptor. Brain Res (2001) 1.10
The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology (1985) 1.10